Evidence map›Paper›PMID 39354488›Full record

Trial reportBMC women's health2024

Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study.

Michelle T Harder, Moliehi Mokete, Frédérique Chammartin, Malebanye Lerotholi, Lipontso Motaboli, Mathebe Kopo, Mpho Kao, Moleboheng Mokebe, Ntoiseng Chejane, Palesa Mahlatsi and 5 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in BMC women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04527874 (Assessment of a Viral Load Result-driven Automated Differentiated Service Delivery Model for Participants Taking Antiretroviral Therapy in Lesotho), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04527874 nacompletednot on this map

Assessment of a Viral Load Result-driven Automated Differentiated Service Delivery Model for Participants Taking Antiretroviral Therapy in Lesotho

TypeinterventionalSponsorSwiss Tropical & Public Health InstituteRan2020 to 2024Enrolled5,809ConditionsHIV InfectionsArmsVITAL model
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michelle T HarderDivision of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland.
Moliehi MoketeSolidarMed, Partnerships for Health, Maseru, Lesotho.
Frédérique ChammartinDivision of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland.
Malebanye LerotholiDivision of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland.
Lipontso MotaboliSolidarMed, Partnerships for Health, Maseru, Lesotho.
Mathebe KopoSolidarMed, Partnerships for Health, Maseru, Lesotho.
Mpho KaoSolidarMed, Partnerships for Health, Maseru, Lesotho.
Moleboheng MokebeSolidarMed, Partnerships for Health, Maseru, Lesotho.
Ntoiseng ChejaneSolidarMed, Partnerships for Health, Maseru, Lesotho.
Palesa MahlatsiSolidarMed, Partnerships for Health, Maseru, Lesotho.
Morongoe NyakaneMinistry of Health Lesotho, Maseru, Lesotho.
Tapiwa TarumbiswaMinistry of Health Lesotho, Maseru, Lesotho.
Niklaus D LabhardtDivision of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland.
Nadine Tschumi *Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland. nadine.tschumi@usb.ch.
Jennifer M Belus *Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel, Totengässlein 3, Basel, 4051, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is the fourth most common cancer in women worldwide, and women with human immunodeficiency virus (HIV) are particularly at risk of developing it. Regular screening effectively prevents morbidity and mortality. This mixed-methods study quantitatively assessed cervical cancer screening uptake and qualitatively explored the process of undergoing cervical cancer screening to understand possible reasons for delayed screening among women with HIV in Lesotho.

methodsBetween October 2020 and March 2022, the Viral load Triggered ART care in Lesotho (VITAL) trial enrolled women aged 18 years and older with HIV who were taking antiretroviral therapy (ART). Cervical cancer screening delay was defined as reporting a screening that occurred more than two years ago or never having been screened. Cervical cancer screening uptake and the association between screening delay and sociodemographic variables were assessed using a multivariable mixed-effects logistic regression model accounting for clustering at clinic level. In-depth interviews were conducted with 16 women to obtain information on awareness, perceptions, and barriers to cervical cancer screening and were analyzed using thematic analysis.

resultsQuantitative data were available for 3790 women. Among them, cervical cancer screening was delayed in 1814 (47.9%), including 1533 (40.5%) who were never screened. Compared to women aged 25 to 39 years, women aged 18 to 24 years (adjusted odds ratio (aOR) 2.8; 95% confidence interval (CI) 2.1-3.7), women aged 40 to 59 years (aOR 1.3; CI 1.1-1.6), and women older than 60 years (aOR 3.9; CI 3.0-5.1) were at higher risk of screening delay. Furthermore, time on ART below 6 months (aOR 1.6; CI 1.1-2.3) compared to above 6 months was associated with screening delay. Qualitative data identified limited awareness of cervical cancer risks and screening guidelines, misconceptions and fears created by the influence of other women's narratives, and low internal motivation as the main barriers to screening uptake.

conclusionsCervical cancer screening delay was common. Limited personal awareness and motivation as well as the negative influence of other women were the primary internal barriers to cervical cancer screening. Awareness and screening campaigns in Lesotho should consider these factors.

trial registrationclinicaltrials.gov, NCT04527874, August 27, 2020.

Indexed as

Early Detection of CancerHIV InfectionsUterine Cervical NeoplasmsAdolescentAdultFemaleHealth Knowledge, Attitudes, PracticeHumansLesothoMass ScreeningMiddle AgedPatient Acceptance of Health CareYoung AdultAccess to careAfricaCervical cancer screeningHIVLesothoMixed-methodsQualitative research

Identifiers

PMID39354488
PMCPMC11446098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.